000			02254 a2200685 4500
005			20250517140430.0
264		0	_c20170808
008			201708s 0 0 eng d
022			_a1528-0012
024	7		_a10.1053/j.gastro.2017.01.050 _2doi
040			_aNLM _beng _cNLM
100	1		_aJacobson, Ira M
245	0	0	_aSafety and Efficacy of Elbasvir/Grazoprevir in Patients With Hepatitis C Virus Infection and Compensated Cirrhosis: An Integrated Analysis. _h[electronic resource]
260			_bGastroenterology _c05 2017
300			_a1372-1382.e2 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAmides
650	0	4	_aAntiviral Agents _xadverse effects
650	0	4	_aBenzofurans _xadverse effects
650	0	4	_aCarbamates
650	0	4	_aClinical Trials, Phase II as Topic
650	0	4	_aClinical Trials, Phase III as Topic
650	0	4	_aCyclopropanes
650	0	4	_aDrug Combinations
650	0	4	_aDrug Resistance, Viral _xgenetics
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aHepacivirus _xgenetics
650	0	4	_aHepatitis C, Chronic _xcomplications
650	0	4	_aHumans
650	0	4	_aImidazoles _xadverse effects
650	0	4	_aLiver Cirrhosis _xphysiopathology
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aQuinoxalines _xadverse effects
650	0	4	_aRNA, Viral _xblood
650	0	4	_aRandomized Controlled Trials as Topic
650	0	4	_aRetreatment
650	0	4	_aRetrospective Studies
650	0	4	_aRibavirin _xtherapeutic use
650	0	4	_aSulfonamides
650	0	4	_aSustained Virologic Response
650	0	4	_aViral Nonstructural Proteins _xgenetics
650	0	4	_aYoung Adult
700	1		_aLawitz, Eric
700	1		_aKwo, Paul Y
700	1		_aHézode, Christophe
700	1		_aPeng, Cheng-Yuan
700	1		_aHowe, Anita Y M
700	1		_aHwang, Peggy
700	1		_aWahl, Janice
700	1		_aRobertson, Michael
700	1		_aBarr, Eliav
700	1		_aHaber, Barbara A
773	0		_tGastroenterology _gvol. 152 _gno. 6 _gp. 1372-1382.e2
856	4	0	_uhttps://doi.org/10.1053/j.gastro.2017.01.050 _zAvailable from publisher's website
999			_c26876450 _d26876450